@MaximMoinat , its great to have you and the team exploring neufofibromatosis! This is a nice clinical description and 5 cohort logical definition varients, so I’m keen to watch this one progress and learn, as its an area I’m not familiar with.
And just to be clear for all, there is no ‘permission’ needed to explore phenotypes. We encourage everyone to work on any phenotypes of interest to them and share their experience here on the forums. The more, the merrier! Phenotype Phebruary is a great chance for us to all focus and learn together!